COMP <GO>
FTAI vs TMO // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
FTAI Aviation Ltd. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: FTAI 6
— TMO 9
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: FTAI
LAST: $187.27 (-4.46%) • MKT CAP: $20.13B
options-implied-move
6.60%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
options-implied-move
6.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FTAI VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FTAI | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 46.20% | 41.00% | +5.20 | FTAI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.00% | 9.30% | +8.70 | FTAI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 51.6x | 30.4x | +21.20 | TMO | /valuation <GO> |
| Free Cash Flow Yield | -1.68% | 2.40% | -4.08 | TMO | /fcf-yield <GO> |
| Operating Margin | 15.70% | 17.40% | -1.70 | TMO | /operating-margins <GO> |
| Net Profit Margin | 12.20% | 15.10% | -2.90 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 44.50% | 3.90% | +40.60 | FTAI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.64% | 0.24% | +0.40 | FTAI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.42 | 4.50 | -0.08 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 6.60% | 6.70% | -0.10 | FTAI | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.3 | 59.1 | +0.12 | FTAI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 0.94 | -0.04 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 55.1x | 36.3x | +18.80 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $20.13B | $262.22B | -$242.09B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FTAI REV | TMO REV | FTAI GROSS % | TMO GROSS % | FTAI FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.51B | $44.56B | 46.2% | 44.0% | -$338.5M | $6.29B |
| FY 2024 | $1.73B | $42.88B | 52.4% | 44.0% | -$197.2M | $7.27B |
| FY 2023 | $1.17B | $42.86B | 44.0% | 44.0% | $76.3M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FTAI // BETA 0.90
TMO // BETA 0.94